Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes Mellitus
Status:
RECRUITING
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is a prospective multicenter randomized controlled trial with a total duration of 36 months aiming to evaluate the effectiveness and the safety of low protein diet on top of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and renin-angiotensin-aldosterone inhibitors (RAASi) in reducing the progression of chronic kidney disease in patients with type 2 Diabetes Mellitus
Phase:
PHASE4
Details
Lead Sponsor:
Anemia Working Group Romania
Collaborators:
Carol Davila University of Medicine and Pharmacy Dr Carol Davila Teaching Hospital of Nephrology, Nephrology Department, Bucharest, Romania Sf Ioan Emergency Clinical Hospital, Nephrology and Dialysis Department, Bucharest, Romania